Scinai Immunotherapeutics Ltd. (TLV:BVXV)

Scinai Immunotherapeutics Revenue

Scinai Immunotherapeutics had revenue of $489.00K USD in the quarter ending March 31, 2026, a decrease of -16.55%. This brings the company's revenue in the last twelve months to $1.21M, down -2.41% year-over-year. In the year 2025, Scinai Immunotherapeutics had annual revenue of $1.31M with 99.24% growth.

• Revenue (ttm): $1.21M
• Revenue Growth: -2.41%
• P/S Ratio: 0.84
• Revenue / Employee: $26.98K
• Employees: 45
• Market Cap: 3.21M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.31M	653.00K	99.24%
Dec 31, 2024	658.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error